Please Wait
Applying Filters...
menu
    • menu
    Default Key Product, Service and Excipients
    News
    Tiefenbacher API+ Ingredients Offers Custom Synthesis Of Intermediates & Apis

    08 May 2024

    // PRESS RELEASE

    Tiefenbacher Group Renovation Of Headquarters In Hamburg

    02 May 2024

    // PRESS RELEASE

    Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban.

    09 Apr 2024

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Tiefenbacher Group

    Contact Supplier

    Website

    BIO Partnering at JPM

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/cdmo-activity-tracker-lupin-s-cdmo-commissions-oncology-block-in-india-cambrex-axplora-hovione-expand-operations
    Left Arrow
    Right Arrow

    We are the TIEFENBACHER GROUP, Health Pioneers since 1963.

    Related CompaniesRelated Companies

    About

    As a key component of the TIEFENBACHER GROUP, a 100% family-owned leader in healthcare, we offer comprehensive solutions across the entire life cycle of pharmaceutical products. Our expertise spans the development, manufacturing, and registration of generic, value-added, and innovative medicines, along with e-health solutions tailored for our B2B clients & distribution partners. Trusted globally, our outstanding capabilities in crafting top-tier dossiers and managing intricate product launches in over 80 countries. Our in-house laboratories and manufacturing facilities in India and Cyprus enable us to establish efficient supply chains.
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.